Julie Hambleton Spring Works Therapeutics, Inc. (SWTX) insider trading activity

Julie Hambleton is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 4,095 shares of SWTX, which is worth approximately $145,741. The most recent transaction as insider was on Jun 03, 2024, when has been sold 4,648 shares (Common Stock) at a price of $40.89 per share, resulting in proceeds of $190,056. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.1K

0% 3M change

11.9% 12M change

Total Value Held $145,741

Julie Hambleton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2024	SELL Open market or private sale	$190,056 $40.89 p/Share	4,648 Reduced 53.16%	4,095 Common Stock
May 16 2024	BUY Grant, award, or other acquisition	-	4,095 Added 31.9%	8,743 Common Stock
Jul 19 2023	SELL Open market or private sale	$70,871 $29.31 p/Share	2,418 Reduced 34.22%	4,648 Common Stock
Jun 20 2023	SELL Open market or private sale	$64,608 $26.92 p/Share	2,400 Reduced 25.35%	7,066 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	4,648 Added 32.93%	9,466 Common Stock
Mar 15 2023	SELL Open market or private sale	$34,839 $31.5 p/Share	1,106 Reduced 18.67%	4,818 Common Stock
May 19 2022	BUY Grant, award, or other acquisition	-	4,818 Added 44.85%	5,924 Common Stock
May 20 2021	BUY Grant, award, or other acquisition	-	1,106 Added 15.58%	5,995 Common Stock

Also insider at

IGMS

IGM Biosciences, Inc. Healthcare

ERAS

Erasca, Inc. Healthcare

Director

Julie Hambleton

Director

Stamford,, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Value

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to SpringWorks Therapeutics, Inc.

Track Activities on SWTX

Account